ABP
Abpro HoldingsยทNASDAQ
--
--(--)
--
--(--)
ABP Profile
Abpro Holdings, Inc.
A cutting-edge biotech company specializing in innovative antibody technology platforms,deeply rooted in the biopharmaceutical sector,focused on developing therapies for major diseases such as oncology,and driving clinical advancement of multiple candidate drugs!
68 Cummings Park Drive, Woburn, MA 01801
--
Abpro Holdings, Inc., was incorporated in Delaware on May 20, 2021. The company is a biotechnology company focused on developing next-generation antibody therapies designed to improve the lives of patients with serious and life-threatening diseases. Abpro focuses on novel antibody construction in immuno-oncology and ophthalmology. By leveraging its proprietary DiversImmune and MultiMabTM antibody discovery and engineering platforms, Abpro is developing a next-generation antibody pipeline independently or through collaborations with global pharmaceutical and research institutions.
